|
Q2 FY2025
As of Jun 30, 2026
|
Q1 FY2025
As of Mar 31, 2026
|
Q4 FY2024
As of Dec 31, 2025
|
Q3 FY2024
As of Sep 30, 2025
|
Q2 FY2024
As of Jun 30, 2025
|
Q1 FY2024
As of Mar 31, 2025
|
Q4 FY2023
As of Dec 31, 2024
|
Q3 FY2023
As of Sep 30, 2024
|
Q2 FY2023
As of Jun 30, 2024
|
Q1 FY2023
As of Mar 31, 2024
|
Q3 FY2022
As of Sep 30, 2023
|
Q2 FY2022
As of Jun 30, 2023
|
Q1 FY2022
As of Mar 31, 2023
|
Q4 FY2021
As of Dec 31, 2022
|
Q3 FY2021
As of Sep 30, 2022
|
Q2 FY2021
As of Jun 30, 2022
|
Q1 FY2021
As of Mar 31, 2022
|
Q4 FY2020
As of Dec 31, 2021
|
Q3 FY2020
As of Sep 30, 2021
|
Q2 FY2020
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Interest-bearing deposits | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Certificates of deposit in other banks | ||||||||||||||||||||
| Debt securities available for sale, at fair value (amortized cost of $146,448 and $141,793 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| FHLB and FRB stock | ||||||||||||||||||||
| SBIC investments | ||||||||||||||||||||
| Loans held for sale, at fair value | ||||||||||||||||||||
| Loans held for sale, at the lower of cost or fair value | ||||||||||||||||||||
| Loans, net of deferred loan fees and costs | ||||||||||||||||||||
| Allowance for credit losses – loans | ||||||||||||||||||||
| Loans, net | ||||||||||||||||||||
| Premises and equipment held for sale, at the lower of cost or fair value | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Deferred income taxes, net | ||||||||||||||||||||
| BOLI | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Core deposit intangibles, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and stockholders' equity | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Junior subordinated debt | ||||||||||||||||||||
| Borrowings | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity | ||||||||||||||||||||
| Preferred stock, $0.01 par value, 10,000,000 shares authorized, none issued or outstanding | ||||||||||||||||||||
| Common stock, $0.01 par value, 60,000,000 shares authorized, 16,727,821 and 17,286,289 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Unearned ESOP shares | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
| Debt securities available for sale, at fair value, amortized cost | ||||||||||||||||||||
Loading...
